Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Retained Earnings (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Retained Earnings data on record, last reported at -$80.1 million in Q4 2025.

  • For Q4 2025, Retained Earnings rose 2.97% year-over-year to -$80.1 million; the TTM value through Oct 2025 reached -$80.1 million, up 2.97%, while the annual FY2025 figure was -$79.9 million, 5.56% up from the prior year.
  • Retained Earnings reached -$80.1 million in Q4 2025 per CSBR's latest filing, roughly flat from -$80.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$71.6 million in Q1 2022 and bottomed at -$84.6 million in Q2 2024.
  • Average Retained Earnings over 5 years is -$77.2 million, with a median of -$77.7 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: fell 13.35% in 2023, then increased 7.62% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$72.4 million in 2021, then increased by 0.17% to -$72.3 million in 2022, then fell by 13.35% to -$82.0 million in 2023, then decreased by 0.73% to -$82.6 million in 2024, then rose by 2.97% to -$80.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$80.1 million in Q4 2025, -$80.4 million in Q3 2025, and -$79.9 million in Q2 2025.